See how top analysts and institutions rate CMG — including buy, hold, and sell recommendations.
| Rating Source | Action | Rating | Target Price | Updated |
|---|---|---|---|---|
| Barclays | Reiterated | Equal Weight | $53 → $43 | 2025-10-22 |
| Bernstein | Reiterated | Outperform | $65 → $60 | 2025-10-02 |
| Rothschild & Co Redburn | Upgrade | Neutral → Buy | $55 | 2025-09-03 |
| Piper Sandler | Upgrade | Neutral → Overweight | $50 | 2025-08-12 |
| BMO Capital Markets | Upgrade | Market Perform → Outperform | $65 | 2025-07-18 |
| Melius | Initiated | Hold | $60 | 2025-07-14 |
| Redburn Atlantic | Initiated | Neutral | $55 | 2025-06-10 |
| Date | Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|---|
| November 2025 | 5 | 21 | 10 | 0 | 0 |
| October 2025 | 5 | 21 | 10 | 0 | 0 |
| September 2025 | 5 | 23 | 8 | 0 | 0 |
| August 2025 | 4 | 22 | 9 | 0 | 0 |
The majority of institutional investors have issued a "Buy" rating for CMG, and analyst sentiment aligns closely, with very few "Sell" recommendations. This suggests a broadly favorable outlook for the stock's performance.
